 Diol-containing renin inhibitors |
| The following table provides a dictionary of the terms used in the description of the invention.
... |
|
| Antitumor agent containing Lactobacillus casei YIT 9018 |
| OF THE INVENTION AND ITS PREFERRED EMBODIMENTS It has been shown that Lactobacillus casei YIT 9018 ... |
|
| Glass composition for alkali-resistant glass fiber |
| What I claim is: 1. A glass composition for alkali-resistant glass fiber, said composition having a ... |
|
| Support matrices for immobilized enzymes |
| We claim as our invention: 1. An organic-inorganic matrix having pendent covalent bonding sites for ... |
|
| Method of producing microbial cells from methane |
| What is claimed is: 1. A method which comprises culturing Methylomonas sp. FERM P-2400 in an ... |
|
| Process for the preparation of L-car-bamyl-amino acids and of the corresponding L-amino acids |
| What we claim is: 1. A process for the preparation of only one of the two stereoisomer forms of ... |
|
| Method for producing D-.alpha.-amino acid |
| What is claimed as new and intended to be secured by Letters Patent is: 1. A method for producing a ... |
|
| Xanthomonas campestris ATCC 31601 and process for use |
| We claim: 1. A method for the production of a heteropolysaccharide which comprises continuously ... |
|
| Enzyme entrappment with cellulose acetate formulations |
| This invention provides an apparatus and method for entrapping enzymes and includes a reactor, ... |
|
| Method of cultivating Methylomonas probus on methanol containing medium |
| OF THE INVENTION The method of this invention comprises the steps of culturing and propagating M... |
|
|
Process for preparing 6-aminopenicillanic acid
| Details |
Inventors: Hamsher, James J.; Lozanov, Merrill;
Assignee: Pfizer Inc. (New York, NY)
Primary Examiner: Tanenholtz; Alvin E.
Assistant Examiner:
Attorney, Agent or Firm: Connolly and Hutz
A simple and efficient process for the deacylation of penicillins to 6-aminopenicillanic acid in which an aqueous penicillin solution is rapidly recirculated through a shallow bed comprising particulate immobilized penicillin acylase at 15.degree.-45.degree. C and pH 6.5-9.0 until substantial conversion results. BACKGROUND OF THE INVENTION This invention relates to penicillins. More specifically, it relates to the enzymatic deacylation of penicillins to 6-aminopenicillanic acid. 6-Aminopenicillanic acid, commonly referred to as 6-APA, is an intermediate in the manufacture of synthetic penicillins and is prepared among other means by the deacylation of penicillins. This conversion has been effected by both chemical and biochemical techniques. The chemical conversion, as exemplified by U.S. Pat. No. 3,499,909, suffers from being a multi-step process requiring energy-intensive low-temperature conditions and specialized equipment. The biochemical conversion utilizes the enzyme penicillin acylase, or penicillin amidase. In U.S. Pat. No. 3,260,653, the enzyme activity is supplied by certain bacteria or bacterial extracts. This approach is not entirely satisfactory for the industrial production of 6-APA since the product stream is contaminated with the enzyme and/or microbial cells, which must then be removed during product recovery, and the enzyme is used only once. The problems of product contamination and poor enzyme utilization are purportedly overcome in U.S. Pat. No. 3,953,291 by the use of immobilized penicillin amidase-producing microbial cells. Such a process using immobilized cells is still characterized by low productivity, however, since in batch operation the process suffers from its non-continuous nature and excessive handling of the immobilized cell material, while in column operation it suffers from poor pH control and less than optimum enzyme utilization. The use of a shallow bed of microbial cell catalyst for the continuous isomerization of glucose to fructose is disclosed in U.S. Pat. Nos. 3,694,314 and 3,817,832. The shallow bed is reportedly employed to minimize the pressure drop through the catalyst, the desired conversion being achieved by passing the aqueous process stream through several beds in series. SUMMARY OF THE INVENTION It has now been found that penicillins can be converted to 6-APA in a simple and efficient manner by rapidly recirculating an aqueous penicillin solution through a shallow bed comprising particulate penicillin acylase catalyst under controlled temperature and pH conditions. Accordingly, the present invention entails a process for the enzymatic conversion of a penicillin to 6-APA which comprises recirculating an aqueous solution of the penicillin through a bed up to about 6 cm deep comprising particulate immobilized penicillin acylase catalyst at a flow rate of at least 0.4 bed volume per minute while maintaining the solution at a temperature of from about 15.degree. to 45.degree. C. and a pH from about 6.5 to 9.0 and continuing the recirculation until the penicillin is substantially converted to 6-APA. Preferably the penicillin is potassium penicillin G, the bed has a depth of from about 2 to 3 cm, the particulate catalyst comprises immobilized Proteus rettgeri cells containing the enzyme, the temperature is about 35.degree. to 40.degree. C. and the pH is from about 7.5 to 8.2. DETAILED DESCRIPTION OF THE INVENTION The process of the present invention, in rapidly recirculating the process stream through a shallow bed of particulate catalyst, is thus able to optimize the conversion of penicillins to 6-APA since it overcomes the heretofore unsolved problems of pH and flow control associated with continuous column deacylation and of excessive catalyst handling with batch deacylations. The capability of the process to control pH is especially significant since the deacylation generates a carboxylic acid which must be neutralized, the enzyme is optimally active over a narrow pH range and both the reactant and product are sensitive to pH extremes. Since this control is accomplished with a minimum of pressure drop through the bed, the process has the further advantage of utilizing standard process equipment. The process is suitable for the deacylation of any water-soluble penicillin. Representative penicillins include but are not limited to penicillin G (benzylpenicillin), penicillin X (p-hydroxybenzylpenicillin) and penicillin V (phenoxymethylpenicillin). Preferred is penicillin G in the form of the potassium or sodium salt. The concentration of the penicillin substrate in the aqueous solution is not critical and normally varies from about 1 to 20 g/100 ml solution. By particulate immobilized penicillin acylase catalyst is meant the enzyme penicillin acylase, or any penicillin acylase-producing microorganism, entrapped within or attached to or on a water-insoluble particulate matrix of organic or inorganic origin in such a manner as to retain the enzyme's activity. Suitable penicillin acylase-producing microorganisms include those belonging to the general of Proteus, Escherichia, Streptomyces, Nocardia, Micrococcus, Pseudomonas, Alkaligenes and Aerobacter such as disclosed in U.S. Pats. Nos. 3,260,653 and 3,953,291. The common methods employed for such immobilization of enzymes and microbial cells include covalent bonding to the matrix, entrapment within the matrix, physical adsorption on the matrix and cross-linking with a bifunctional reagent to form the matrix. Illustrative of these immobilization techniques are those of U.S. Pats. Nos. 3,645,852, 3,708,397, 3,736,231, 3,779,869, 3,925,157, 3,953,291 and 3,957,580. As indicated by these references, the matrix is typically a polymer or copolymer of such monomers as glycidyl methacrylate methacrylic acid anhydride, acryloylamide, acrylamide, styrene, divinylbenzene or glucose, or the matrix may be of such substances as bentonite, powdered carbon, titania, alumina or glass. Preferred catalyst is one in which Proteus rettgeri cells containing penicillin acylase are immobilized by the process of U.S. Pat. No. 3,957,580. Such particulate catalysts will normally have an activity of from about 200 to 5,000 units (micromoles penicillin G deacylated per hour) per gram of dry catalyst. The particulate catalyst is utilized in the form of a shallow bed through which the process stream is rapidly recirculated. By shallow bed is meant a bed having a depth of up to about 6 cm. The actual depth of the bed is determined by the desired productivity of the conversion unit, the activity of the particulate catalyst and, in the case of immobilized microbial cell catalyst, the concentration of cells in the particulate catalyst. The bed should be deep enough to supply sufficient enzyme activity for the desired productivity of the unit and not so deep as to prevent the desired flow discussed hereinafter. At times it may be advisable to admix the catalyst with a particulate material such as diatomaceous earth, perlite or powdered cellulose added in the amount of up to about 80 volume percent of the bed to give the bed a more porous structure. Beds about 1 to 6 cm deep normally meet the desired productivity and flow requirements. Particularly suitable units for preparing such beds include standard filtration equipment such as a horizontal pressure leaf filter or a plate-and-frame filter press. The conversion is run under controlled temperature as well as pH conditions to maximize productivity while minimizing substrate, product and catalyst degradation. The temperature is limited to between about 15.degree. to 45.degree. C and preferably between about 35.degree. and 40.degree. C. The activity of the catalyst drops off considerably at temperatures much below 15.degree. C while temperatures much above 45.degree. C result in considerable decomposition of the penicillin and 6-APA and appreciable denaturization of the catalyst. As indicated hereinbefore, pH control is critical to high conversion of penicillin to 6-APA, and the pH of the process is therefore limited to from about 6.5 to 9.0. A pH much below 6.5 results in considerably reduced enzyme activity and in enhanced penicillin degradation, while a pH much greater than 9.0 accelerates not only penicillin degradation but also enzyme denaturization. The pH is preferably maintained between about 7.5 and 8.2 when the catalyst is derived from Proteus rettgeri. In practice, the bulk of the process stream is maintained at the desired temperature and pH in a stirred tank or reservoir. A small portion of the stream is continuously passed through the catalyst bed and quickly returned to the reservoir where the acid formed during the passage through the bed is neutralized by a suitable base such as sodium hydroxide to maintain the pH within the desired range. Such a system can be adapted to batch, semi-continuous or continuous operation. The flow rate of the process stream through the catalyst bed is also of critical importance in assuring optimum conversion of penicillins to 6-APA, and should be at least 0.4 bed volume per minute. Flow rates much below this value not only cause a considerable reduction of catalyst utilization resulting from poorer diffusion of the substrate and product within the catalyst bed but also enhance the degradation of substrate, product and catalyst from the increase localized acidity present in the bed. The recycling of the process stream through the catalyst bed is continued until the penicillin in the stream has been substantially (at least 80 percent) converted. The 6-APA in the stream may then be either isolated or reacted to a desired penicillin by conventional means. |
|
DETAILED DESCRIPTION What is claimed is: 1.
In the process for the enzymatic conversion of a penicillin to 6-aminopenicillanic acid wherein an aqueous solution of said penicillin is contacted with a particulate immobilized penicillin acylase catalyst, the improvement which comprises recirculating said solution through a bed comprising said particulate catalyst at a flow rate of at least0.
4 bed volume per minute while maintaining said solution at a temperature of from about 15.
degree.
and a pH of from about 6.
5 to 9.
0 and continuing said recirculation until said penicillin is substantially converted to said acid, said bed having a depth of up to about 6 centimeters.
2.
The process of claim 1 wherein said penicillin is potassiun penicillin G.
3.
The process of claim 1 wherein said bed has a depth of from about 2 to 3 centimeters.
4.
The process of claim 1 wherein said particulate catalyst comprises immobilized Proteus rettgeri cells containing said enzyme.
5.
The process of claim 1 wherein said temperature is from about 35.
degree.
to 40.
degree.
C and said pH is from about 7.
5 to 8.
2.
Description:
The following examples merely illustrate the process of the present invention and are not to be construed as limiting the invention, the scope of which is defined by the appended claims.
EXAMPLE 1 A Proteus rettgeri [ATCC 31052 (ATCC 9250); Pfizer Culture 18470-76-60] fermentation broth, grown under submerged aerobic conditions at 28.
degree.
C.
and pH 6.
8-7.
0 on lactic casein substrate, was centrifuged and the separated cells were washed with water.
A suspension of 317 kg of the washed cells in 2120 liters of water was treated with 16.
3 kg of 25 weight percent aqueous glutaraldehyde and stirred for 17 minutes at 21.
degree.
C.
To the treated suspension under nitrogen was added 162.
6 kg glycidyl methacrylate and the suspension was stirred for 2 hours at 22.
degree.
C.
Then 30.
4 kg N,N'-methylenebisacrylamide, 27.
6 kg dimethylaminopropionitrile and 3.
3 kg ammonium persulfate were added and the mixture, at pH 7
|
| Related patents |
|
|
Process for making T cell hybridomas
We claim: 1. A process for making a T cell hybridoma comprising: a. Fusing an azaserine-hypoxanthine sensitive human T leukemia cell line with normal human T cells; and ...
|
|
|
Reinforced cement
OF THE INVENTION Fiber suitable for cement reinforcement in accordance with the present invention is p-aramid fiber and acrylic fiber. The term "aramid" is used to ...
|
|
|
Treated patch for minor cuts
I claim: 1. An article for covering a cut area in the skin, comprising a substantially centrally disposed layer of liquid absorbable pad means containing at least a ...
|
|
|
Melanin inhibiting cosmetic composition
OF THE INVENTION The placenta extracts which are employed in the present invention are aqueous solutions obtained by extracting water-soluble portions with water via ...
|
|
|
Microorganisms for biodegrading toxic chemicals
I claim: 1. A biologically pure culture of a microorganism selected from the group consisting of Methylobacter rhodinum ATCC 113-X and Methylobacter species ATCC 138-X. 2...
|
|
|
Bacterial method and compositions for degrading hydrocarbons
I claim: 1. A bacterial composition which comprises a mixture of: (a) Pseudomonas putida strain NRRL-B-18117; and (b) Pseudomonas putida strain NRRL-B-18118 wherein the ...
|
|
|
Elastomer screen units for shaker-screen bodies
As previously stated, the sectional screen units of this invention connected in multiplicity are particularly adapted for sizing and sifting fragmented, hard-stock ...
|
|
|
Ionic compounds formed from iron and urea
Having described the invention, what is claimed is: 1. As a new compound for correcting iron deficiency in plants aquocarbamide iron II sulfate, corresponding to the ...
|
|
|
Enzymatic reagent system for total cholesterol assay using oxygen-rate method
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A cholesterol assay enzymatic reagent for rate ...
|
|
|
Photochromic boro-silicate glass
OF THE INVENTION Specific embodiments of the invention will now be described in more detail by way of example and with reference to the following table, which sets out ...
|
|
|
Molecular Biology 
